NDC 0641-6103-01 - ROBAXIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6103
- Requested NDC
- 0641-6103-01
- Package NDCs from labels
- 0641-6103-01, 0641-6103-10, 0641-6103-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ROBAXIN Injectable (methocarbamol injection, USP) | Hikma Pharmaceuticals USA Inc. | 2024-04-10 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6103-01 | ROBAXIN | 10 mL in 1 VIAL | INJECTION | 10 | 8 | |
| 0641-6103-10 | ROBAXIN | 10 in 1 CARTON | INJECTION | 10 | 8 | |
| 0641-6103-25 | ROBAXIN | 25 in 1 CARTON | INJECTION | 25 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6103-01 | ML - Milliliter | 0641-6103 | fea093a9-e51d-4877-9285-77155bc4380f | 1 | 2013-02-13 |
| 0641-6103-10 | ML - Milliliter | 0641-6103 | 86079302-612f-4f5d-8af4-0b2d1fa573d8 | 1 | 2024-03-12 |
| 0641-6103-25 | ML - Milliliter | 0641-6103 | e99128e7-032f-45f6-bb13-8e212a583b26 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METHOCARBAMOL | ACTIVE INGREDIENT | 125OD7737X | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| METHOCARBAMOL | ACTIVE MOIETY | 125OD7737X | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| POLYETHYLENE GLYCOL 300 | INACTIVE INGREDIENT | 5655G9Y8AQ | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ROBAXIN (METHOCARBAMOL) INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL TABLETS | Coupler LLC | 5a585c87-6361-420d-e063-6294a90a1838 | 2026-08-31 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Cardinal Health 107, LLC | 05b287d3-5004-4d8b-9ebe-a96caa2b8d89 | 2026-08-27 | Warnings, Adverse reactions | 125OD7737X |
| KUGIG ALOE FOAMING INTIMATE WASH | INTIMATE CLEANSING FOAM | Hong Kong KangXing Centennial Management Limited | 59f4d398-1186-a168-e063-6294a90ab44b | 2026-08-26 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | REMEDYREPACK INC. | 5dd5d148-6e23-41de-bff5-551b2aea9598 | 2026-08-24 | Warnings, Adverse reactions | 059QF0KO0R |
| BM BM63 DROPS | CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN | BM Private Limited | 59006d82-610a-2e08-e063-6394a90af1ed | 2026-08-14 | Warnings | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 1dc3a5b1-c83b-406b-a59d-ce8075e4ccf9 | 2026-08-10 | Warnings, Adverse reactions | 125OD7737X |
| Sterile Water | WATER | Cardinal Health 107, LLC | 48d75a7c-8329-48a8-bea0-a8c144ddf637 | 2026-08-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL | St. Mary's Medical Park Pharmacy | 56090def-7caf-e916-e063-6294a90a6ac2 | 2026-08-05 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Coupler LLC | 5827d07b-a0a4-a543-e063-6294a90ad565 | 2026-08-03 | Warnings, Adverse reactions | 125OD7737X |
| Garzulys | INSULIN ASPART-FSAN | Meitheal Pharmaceuticals Inc. | 30c64769-d2f7-4604-ac9e-2a6bc09506c9 | 2026-07-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL | American Health Packaging | d842fe4e-fc46-4d70-9ca3-b47191672f96 | 2026-07-30 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Medcore LLC | 1a6b7327-fd42-4de0-bd0d-2dd478502d52 | 2026-07-29 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 3d4a2486-863e-4e9f-be3b-67882863e7d4 | 2026-07-29 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6b9ed3a4-46d5-462e-ac93-6b959b314d77 | 2026-07-29 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | adb49cb7-8900-44dc-add0-22e2cd8235ac | 2026-07-29 | Warnings, Adverse reactions | 125OD7737X |
| DECONIMO Reconstitution | DECONIMO RECONSTITUTION | Image Amazon LLC | 57ab9b1c-9a18-3786-e063-6394a90a2c63 | 2026-07-28 | Warnings | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 0deb5368-ffdc-40fc-a97c-ba89b7a97e50 | 2026-07-21 | Warnings, Adverse reactions | 125OD7737X |
| Sterile Water | WATER | Cardinal Health 107, LLC | 9655cd02-82b5-4a75-813b-854b19551481 | 2026-07-21 | Warnings, Adverse reactions | 059QF0KO0R |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 52b20439-6bf4-435e-817a-c3b3fc70846a | 2026-07-10 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 37767123-8b72-4e1f-b00d-ff3305e9923f | 2026-07-10 | Warnings, Adverse reactions | 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.